SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-357380
Filing Date
2021-12-15
Accepted
2021-12-15 07:05:57
Documents
14
Period of Report
2021-12-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d212746d8k.htm   iXBRL 8-K 43602
2 EX-99.1 d212746dex991.htm EX-99.1 61886
  Complete submission text file 0001193125-21-357380.txt   334962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lly-20211215.xsd EX-101.SCH 6215
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lly-20211215_def.xml EX-101.DEF 17002
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lly-20211215_lab.xml EX-101.LAB 29396
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lly-20211215_pre.xml EX-101.PRE 18555
7 EXTRACTED XBRL INSTANCE DOCUMENT d212746d8k_htm.xml XML 15940
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 211493080
SIC: 2834 Pharmaceutical Preparations